HOME >> MEDICINE >> NEWS
Gene mutations predict which lung cancers will respond to Iressa

Researchers from the Massachusetts General Hospital (MGH) Cancer Center have discovered a molecular marker that identifies lung cancer patients whose tumors will respond to treatment with the drug Iressa (gefitinib). Their findings, which will be published in the May 20 New England Journal of Medicine, are being released online today to coincide with the online release by Science of related research from Dana-Farber Cancer Institute.

"This discovery will help us significantly improve the treatment of many lung cancer patients and is also an important next step in the molecular targeting of cancer drugs," says Daniel Haber, MD, PhD, director of the MGH Cancer Center and senior author of the NEJM paper. "We're hopeful that what we have learned will eventually lead to more new drugs that will target tumor-specific mutations without affecting normal tissues."

Iressa was approved a year ago for the treatment of advanced non-small-cell lung cancer (NSCLC), a tumor that is particularly difficult to treat and is the leading cause of cancer deaths in the U.S. In a major clinical trial Iressa caused tumors to shrink significantly in only 13.6 percent of patients, but some of those responses were rapid and dramatic. As a result, the FDA approved the drug because there are no other treatment options for NSCLC patients for whom standard chemotherapy has failed.

Iressa acts by disabling the epidermal growth factor receptor (EGFR) on the surface of lung cancer cells, halting a sequence of signals that can lead to the uncontrolled growth characterizing a malignant tumor. In their search for an answer to why the drug worked so well for some NSCLC patients but was of no assistance to others, the MGH team screened tumor samples from MGH patients who participated in the Iressa clinical trial to search for mutations in the EGFR gene.

Initial analysis found mutations affecting the same area (the ATP cleft of the kinase domain) of the receptor prot
'"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
29-Apr-2004


Page: 1 2 3

Related medicine news :

1. Non-invasive and invasive breast cancers share the same genetic mutations
2. Both inherited traits and tumor mutations affect response to treatment of leukemia
3. Small increases or blips in HIV levels do not signal mutations leading to drug-resistant HIV
4. Gene mutations responsible for childhood cataracts discovered
5. Breast cancer patients with BRCA1 or 2 mutations twice as likely to have double mastectomy
6. Breast cancer patients with BRCA 1/2 mutations twice as likely to choose double mastectomy
7. Mayo Clinic researchers discover gene mutations that ignore stress, lead to heart failure
8. In 15 seconds, new test will ID presence of 25 most common mutations of cystic fibrosis
9. Northwestern on trail of gene mutations that trigger sex reversal
10. Gene mutations found that lead to prostate cancer in mice new mouse model developed to study the disease
11. New evaluation tool reliably predicts recovery from coma

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/7/2018)... (PRWEB) , ... September 07, 2018 , ... Start your ... with 12 different sports experiences from which to choose. Pedal power is the name ... Repair Drag Strip Experience or turning left on the miniature Indianapolis Motor Speedway oval. ...
(Date:9/2/2018)... ... September 02, 2018 , ... Eaton Hotel ... change. The hotel itself, which opened this week, inspires creativity and innovation among ... more. , Eaton Hotel DC currently features 209 hotel rooms, a wellness center, ...
(Date:8/31/2018)... (PRWEB) , ... August 31, 2018 , ... ... hospitals | 2018" list. , This list includes independent community hospitals as well ... while others care for small communities outside of large cities. The hospitals continue ...
(Date:8/31/2018)... ... August 31, 2018 , ... Nitro Circus hosted the inaugural A ... – an action sports gathering to celebrate the life of Erik Roner, world-renowned skier, ... for Erik’s wife, Annika and their two small children, Oskar (8) and Kasper (4). ...
(Date:8/31/2018)... ... August 31, 2018 , ... ... Inc.’s “hit” list. The company, a small molecule drug discovery and development ... September 2017 with a mission to develop a first-in-class therapeutic targeting rare ...
Breaking Medicine News(10 mins):
(Date:9/7/2018)... ... ... New York City is currently the epicenter of the tennis world, as ... fourth and final jewel in the 2018 grand slam crown – The US Open. ... the players’ footwork be highlighted. , “Today’s tennis isn’t that of your grandmother,” says ...
(Date:9/1/2018)... ... August 31, 2018 , ... Precision Orthopedics & Sports Medicine ... in Irving and Southlake. Fellowship trained in Spine Surgery, Dr. Gengler will practice ... John Milani, Dr. Jaytinder Sandhu, and Dr. Tariq Hendawi beginning September 4, 2018. ...
(Date:9/1/2018)... ... September 01, 2018 , ... The 2017 ... on the company’s continued efforts to “Create a Better Future” through a focus ... of natural resources. , “2017 was a positive year for Shaw, as ...
Breaking Medicine Technology:
Cached News: